U.S. Healthtech Stock News

AEye (LIDR) has just joined the NVIDIA Halos AI Systems Inspection Lab while also releasing fourth quarter and full year 2025 results, a combination that puts both its technology partnerships and financial profile in focus. See our latest analysis for AEye. The share price has been volatile around these announcements, with a 7 day share price return of 44.52% and a 1 day decline of 13.51%. Over 1 year, the total shareholder return is very large compared to the longer term 3 year and 5 year...

Recent share performance and business snapshot Henry Schein (HSIC) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months, despite a modest positive 1 year total return. The company provides a broad range of health care products and services, with revenue of US$13.2b and net income of US$398.0m, primarily through its Global Distribution and Value Added Services segment. See our latest...

If you are wondering whether Catalyst Pharmaceuticals at around US$22.79 is priced high, low, or just about fair, this article breaks down what the current tag might really mean for you. The stock has seen mixed returns, with a 2.2% decline over the last week, a 6.2% decline over the last month, a 1.6% decline year to date, but a 38.6% gain over 3 years and a very large gain over 5 years. Recent coverage has focused on how this biopharma name fits into investors’ watchlists, with attention...

VNET Group, Inc. recently reported its fourth-quarter and full-year 2025 results, showing quarterly revenue rising to CNY 2,687.09 million and a swing to CNY 304.67 million in net income, while providing 2026 full-year revenue guidance of RMB 11.5 billion to RMB 11.8 billion and announcing the resignation of director Jianbiao Zhu on March 9, 2026. An interesting takeaway is that despite generating CNY 9,949.26 million in 2025 sales and returning to profitability in the latest quarter, VNET...

Wayfair stock reaction and recent performance snapshot Wayfair (W) shares have been under pressure recently, with the stock showing a 5.1% decline over the past day and an 8.5% drop over the past week, prompting closer attention from investors. Over the past month the stock is down 11.2%, and over the past 3 months it has declined 28.8%, while the most recent close sits at US$72.35 and the company’s market value is about US$9.46b. See our latest analysis for Wayfair. Despite the recent...

Recent share performance and business snapshot Americold Realty Trust (COLD) has seen its share price come under pressure, with a last close of US$11.25. Negative total returns over the past year and the past 3 months have drawn investor attention. The company operates 231 temperature controlled facilities across multiple regions. It generates US$2,599.734 in revenue, primarily from warehouse services, transportation, and third party managed operations in North America, Europe, Asia Pacific,...

Why Maximus Stock Is Back on Investors’ Radar Maximus (MMS) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. At the same time, the company reports annual revenue of US$5.37b and net income of US$371.78m, supported by modest annual growth in both metrics. This gives investors concrete figures to assess against recent price moves. See our latest analysis for Maximus. Despite a...

Recent performance snapshot Antero Resources (AR) has drawn fresh attention after a recent move in its share price, with the stock returning 21.24% over the past month and 28.17% over the past 3 months. See our latest analysis for Antero Resources. The recent 21.24% 1 month share price return, alongside a 28.17% 3 month gain and a 25.96% year to date move at a US$43.09 share price, comes on top of a 5.69% 1 year total shareholder return and a much stronger 3 year total shareholder return of...

Assessing whether CareTrust REIT is priced attractively today, or if the easy gains are already behind it, starts with a clear look at what the current share price implies about its value. The stock closed at US$36.10, with returns of 29.8% over 1 year and very large gains over 3 and 5 years, while the last 7 and 30 days show declines of 10.0% and 9.9% and the year to date move is a modest 0.6% decline. Recent market attention has focused on CareTrust REIT as a health care focused real...

This article examines whether Pentair, trading at around US$86.49, is offering fair value or a mispriced opportunity by breaking down what the current share price might be implying about the company. Over the past month the stock has recorded a 15.2% decline and an 18.0% decline year to date, while the 3 year and 5 year returns of 69.8% and 48.2% provide a longer term contrast to the recent 2.6% 7 day move and 2.8% 1 year decline. Recent market attention on Pentair has been shaped by ongoing...

Earnings, guidance, and buybacks reshape the Macy's (M) story Macy's (M) is back in focus after issuing 2026 earnings guidance, reporting fourth quarter and full year results, and updating investors on the completion of a multi year share repurchase program. See our latest analysis for Macy's. Macy's recent 2026 guidance, Q4 earnings, and completion of the buyback program have all landed against a mixed backdrop, with a 7 day share price return of 4.56% alongside a 30 day share price return...

Tesla (NasdaqGS:TSLA) and SpaceX are launching Terafab, an AI chip factory complex in Austin, Texas, to supply chips for vehicles, humanoid robots, and AI space data centers. The Terafab project links automotive and aerospace chip needs within a single vertically controlled manufacturing hub. Tesla is planning a US$2.9b purchase of solar manufacturing equipment from Chinese suppliers to build out 100 gigawatts of U.S. solar production capacity by 2028. These projects represent...

Why a European patent ruling has IPG Photonics (IPGP) back in focus IPG Photonics (IPGP) is under renewed scrutiny after the Unified Patent Court in Düsseldorf found that certain uses and designs of its adjustable mode beam lasers infringe a Trumpf patent, affecting products in Germany, France and Italy. The ruling currently applies to AMB lasers that represent less than 1% of company sales. However, potential remedies such as an injunction, recall or damages, along with IPG’s decision to...

If you are wondering whether Morningstar's current share price truly reflects its underlying value, this breakdown will help you put the numbers into context. The stock recently closed at US$179.07, with a 2.0% decline over the last 7 days, a 12.3% gain over 30 days, and returns of a 14.9% decline year to date and a 40.6% decline over the last year. These moves sit against a backdrop of ongoing attention on Morningstar as a data and research provider, with investors weighing how its role in...

Earlier in March 2026, Hims & Hers Health announced that Kathryn Beiser, a veteran of Discover, Kaiser Permanente, Eli Lilly, and Edelman, had joined as Chief Communications Officer to lead its internal and external communications. Her appointment comes just after the company repaired its relationship with Novo Nordisk over weight-loss drugs, highlighting a sharpened focus on branding and stakeholder messaging around its broader telehealth ambitions. We’ll now explore how the renewed Novo...

Why Linde’s recent performance is drawing attention Linde (LIN), a global industrial gas company, is back on many investors’ radars after a solid past 3 months, with the share price posting a total return above 14%. That move follows a longer run of positive multi year total returns and sits alongside annual revenue of US$33.99b and net income of US$6.90b. This combination is prompting closer scrutiny of what is currently priced in. See our latest analysis for Linde. Over the past year,...

Wondering if MDU Resources Group at around US$19.65 is offering value right now, or if the recent run puts it on the expensive side. The stock has pulled back about 4.7% over the past week and 2.9% over the past month, although the 1 year return sits at 18.7% and the 3 and 5 year returns are 91.5% and 89.5% respectively. Recent coverage has focused on MDU Resources Group as a regulated utility and infrastructure business. Investors are paying attention to how its mix of operations and...

EMCOR Group (NYSE:EME) has been added to the FTSE All-World Index. This index inclusion is effective with the latest rebalance of FTSE Russell global benchmarks. The move may draw additional attention from institutional and index tracking investors. For EMCOR Group, trading at $724.93, inclusion in a global benchmark index comes after a very large 5 year return and a 76.0% return over the past year. Even with a 10.8% decline over the past 30 days and a 0.2% decline over the past week, the...

If you are asking whether Sunoco shares are still reasonably priced after a strong run, the answer depends on how you look at value and which metrics you trust most. With the stock at US$64.73, recent returns have been mixed, including a 0.4% decline over the last 7 days, a 3.5% gain over 30 days, 22.8% year to date, 21.4% over 1 year, 85.4% over 3 years, and 184.2% over 5 years. Investor attention has been shaped by ongoing coverage of Sunoco's role in the US energy sector, including...

Why Syndax Pharmaceuticals (SNDX) Is Drawing Investor Attention Now Syndax Pharmaceuticals (SNDX) has been catching investor interest after recent trading, with the stock last closing at US$24.23 and recent returns over the month and past 3 months standing out in the biotech space. See our latest analysis for Syndax Pharmaceuticals. For context, Syndax Pharmaceuticals has a 30 day share price return of 23.06% and a year to date share price return of 13.76%, while the 1 year total shareholder...

Investors may be wondering if Astera Labs at around US$116 per share still offers value after a big run, or if they might be late to the story. The stock is up 63.2% over the last year, although the 7 day, 30 day and year to date returns of 3.5%, 10.5% and 35.4% declines show that enthusiasm has cooled recently. Recent coverage has focused on Astera Labs as a key player in semiconductor infrastructure and AI related hardware. This helps explain why the share price has attracted attention...

Earlier in March 2026, Ambarella outlined its expanding Edge AI strategy at the Cantor Fitzgerald Global Technology and Industrial Growth Conference, revealing that Edge AI now contributes 80% of revenue and grew 50% over the prior year while also launching indirect sales channels and a semi-custom chip program targeting a future two-nanometer design. This shift toward a higher-mix Edge AI portfolio, coupled with plans for advanced semi-custom chips, marks a meaningful evolution in how...

Why International Seaways is on investors’ radar International Seaways (INSW) has drawn fresh attention after recent trading, with the share price around $67.75 and total return over the past 3 months and year highlighting how tanker exposure has recently played out for holders. See our latest analysis for International Seaways. The recent 1 day share price return of a 5.3% decline contrasts with a 41.5% 3 month share price gain and a very large 5 year total shareholder return. This suggests...

Franklin Resources, Inc. was recently removed from the FTSE All-World Index (USD), a move that may trigger portfolio rebalancing among index-tracking funds and institutional investors. This index exclusion puts a spotlight on how much of Franklin Resources’ investor base relies on benchmark-linked capital versus active, discretionary ownership. We’ll now examine how Franklin Resources’ removal from the FTSE All-World Index could reshape its investment narrative and future capital...